These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9367152

  • 1. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity.
    Ohki-Hamazaki H, Watase K, Yamamoto K, Ogura H, Yamano M, Yamada K, Maeno H, Imaki J, Kikuyama S, Wada E, Wada K.
    Nature; 1997 Nov 13; 390(6656):165-9. PubMed ID: 9367152
    [Abstract] [Full Text] [Related]

  • 2. Development and function of bombesin-like peptides and their receptors.
    Ohki-Hamazaki H, Iwabuchi M, Maekawa F.
    Int J Dev Biol; 2005 Nov 13; 49(2-3):293-300. PubMed ID: 15906244
    [Abstract] [Full Text] [Related]

  • 3. Generation and characterization of mice lacking gastrin-releasing peptide receptor.
    Wada E, Watase K, Yamada K, Ogura H, Yamano M, Inomata Y, Eguchi J, Yamamoto K, Sunday ME, Maeno H, Mikoshiba K, Ohki-Hamazaki H, Wada K.
    Biochem Biophys Res Commun; 1997 Oct 09; 239(1):28-33. PubMed ID: 9345264
    [Abstract] [Full Text] [Related]

  • 4. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM, Nitecki DE, Biancalana S, Feldman RI.
    Mol Pharmacol; 1996 Nov 09; 50(5):1355-63. PubMed ID: 8913368
    [Abstract] [Full Text] [Related]

  • 5. Appetite-modifying effects of bombesin receptor subtype-3 agonists.
    Majumdar ID, Weber HC.
    Handb Exp Pharmacol; 2012 Nov 09; (209):405-32. PubMed ID: 22249826
    [Abstract] [Full Text] [Related]

  • 6. Biology and pharmacology of bombesin receptor subtype-3.
    Majumdar ID, Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb 09; 19(1):3-7. PubMed ID: 22157398
    [Abstract] [Full Text] [Related]

  • 7. Bombesin receptor subtype-3 is expressed by the enteric nervous system and by interstitial cells of Cajal in the rat gastrointestinal tract.
    Porcher C, Juhem A, Peinnequin A, Bonaz B.
    Cell Tissue Res; 2005 Apr 09; 320(1):21-31. PubMed ID: 15726424
    [Abstract] [Full Text] [Related]

  • 8. Leptin resistance and enhancement of feeding facilitation by melanin-concentrating hormone in mice lacking bombesin receptor subtype-3.
    Maekawa F, Quah HM, Tanaka K, Ohki-Hamazaki H.
    Diabetes; 2004 Mar 09; 53(3):570-6. PubMed ID: 14988239
    [Abstract] [Full Text] [Related]

  • 9. Mutation in bombesin receptor subtype-3 gene is not a major cause of obesity in the Japanese.
    Hotta K, Matsukawa Y, Nishida M, Kotani K, Takahashi M, Kuriyama H, Nakamura T, Wada K, Yamashita S, Funahashi T, Matsuzawa Y.
    Horm Metab Res; 2000 Jan 09; 32(1):33-4. PubMed ID: 10727011
    [Abstract] [Full Text] [Related]

  • 10. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA, Coy DH, Entsuah LK, Jensen RT.
    J Pharmacol Exp Ther; 2004 Sep 09; 310(3):1161-70. PubMed ID: 15102928
    [Abstract] [Full Text] [Related]

  • 11. Cloning, expression, and mapping of a gene that is upregulated in adipose tissue of mice deficient in bombesin receptor subtype-3.
    Aoki K, Sun YJ, Aoki S, Wada K, Wada E.
    Biochem Biophys Res Commun; 2002 Feb 01; 290(4):1282-8. PubMed ID: 11812002
    [Abstract] [Full Text] [Related]

  • 12. Anatomical characterization of bombesin receptor subtype-3 mRNA expression in the rodent central nervous system.
    Zhang L, Parks GS, Wang Z, Wang L, Lew M, Civelli O.
    J Comp Neurol; 2013 Apr 01; 521(5):1020-39. PubMed ID: 22911445
    [Abstract] [Full Text] [Related]

  • 13. Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.
    Ladenheim EE, Hamilton NL, Behles RR, Bi S, Hampton LL, Battey JF, Moran TH.
    Endocrinology; 2008 Mar 01; 149(3):971-8. PubMed ID: 18039774
    [Abstract] [Full Text] [Related]

  • 14. Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor.
    Ohki-Hamazaki H, Sakai Y, Kamata K, Ogura H, Okuyama S, Watase K, Yamada K, Wada K.
    J Neurosci; 1999 Feb 01; 19(3):948-54. PubMed ID: 9920658
    [Abstract] [Full Text] [Related]

  • 15. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D, Berger C, Heinrich T, Eickelmann P, Antel J, Kessler H.
    J Pept Sci; 2002 Aug 01; 8(8):461-75. PubMed ID: 12212809
    [Abstract] [Full Text] [Related]

  • 16. Disruption of neuromedin B receptor gene results in dysregulation of the pituitary-thyroid axis.
    Oliveira KJ, Ortiga-Carvalho TM, Cabanelas A, Veiga MA, Aoki K, Ohki-Hamazaki H, Wada K, Wada E, Pazos-Moura CC.
    J Mol Endocrinol; 2006 Feb 01; 36(1):73-80. PubMed ID: 16461928
    [Abstract] [Full Text] [Related]

  • 17. Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
    Metzger JM, Gagen K, Raustad KA, Yang L, White A, Wang SP, Craw S, Liu P, Lanza T, Lin LS, Nargund RP, Guan XM, Strack AM, Reitman ML.
    Am J Physiol Endocrinol Metab; 2010 Nov 01; 299(5):E816-24. PubMed ID: 20807840
    [Abstract] [Full Text] [Related]

  • 18. Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
    Guan XM, Metzger JM, Yang L, Raustad KA, Wang SP, Spann SK, Kosinski JA, Yu H, Shearman LP, Faidley TD, Palyha O, Kan Y, Kelly TM, Sebhat I, Lin LS, Dragovic J, Lyons KA, Craw S, Nargund RP, Marsh DJ, Strack AM, Reitman ML.
    J Pharmacol Exp Ther; 2011 Feb 01; 336(2):356-64. PubMed ID: 21036912
    [Abstract] [Full Text] [Related]

  • 19. Human BRS-3 receptor: functions/role in cell signaling pathways and glucose metabolism in obese or diabetic myocytes.
    Ramos-Álvarez I, Moreno-Villegas Z, Martín-Duce A, Sanz R, Aparicio C, Portal-Núñez S, Mantey SA, Jensen RT, González N.
    Peptides; 2014 Jan 01; 51():91-9. PubMed ID: 24220502
    [Abstract] [Full Text] [Related]

  • 20. Expression of neuromedin B in adipose tissue and its regulation by changes in energy balance.
    Hoggard N, Bashir S, Cruickshank M, Miller JD, Speakman JR.
    J Mol Endocrinol; 2007 Sep 01; 39(3):199-210. PubMed ID: 17766645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.